928 related articles for article (PubMed ID: 9026729)
1. [Differential effect of glucosaminylmuramyl dipeptide on the phenotype of melanoma sublines with different metastatic potential].
Valiakina TI; Malakhov AA; Komaleva RL; Petrova EE; Mikhaĭlov AD; Revazova ES; Nesmeianov VA
Mol Biol (Mosk); 1996; 30(6):1394-401. PubMed ID: 9026729
[No Abstract] [Full Text] [Related]
2. Endogenous tumour necrosis factor-alpha sensitise melanoma cells to glucosaminylmuramyl dipeptide.
Valyakina TI; Komaleva RL; Petrova EE; Malakhov AA; Shamborant OG; Andronova TM; Nesmeyanov VA
FEBS Lett; 1998 Apr; 426(3):373-6. PubMed ID: 9600269
[TBL] [Abstract][Full Text] [Related]
3. A new Mr 55,000 surface protein implicated in melanoma progression: association with a metastatic phenotype.
Boukerche H; Baril P; Tabone E; Bérard F; Sanhadji K; Balme B; Wolf F; Perrot H; Thomas L
Cancer Res; 2000 Oct; 60(20):5848-56. PubMed ID: 11059782
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of metastatic human tumor burden and response to therapy in a nude mouse xenograft model using a molecular probe for repetitive human DNA sequences.
Shoemaker RH; Smythe AM; Wu L; Balaschak MS; Boyd MR
Cancer Res; 1992 May; 52(10):2791-6. PubMed ID: 1581891
[TBL] [Abstract][Full Text] [Related]
5. Tumorigenicity and dissemination of primary and metastatic human melanomas implanted into different sites in athymic nude mice.
Rodolfo M; Balsari A; Clemente C; Parmiani G; Fossati G
Invasion Metastasis; 1988; 8(6):317-31. PubMed ID: 3225146
[TBL] [Abstract][Full Text] [Related]
6. Modulation by MHC class I antigens of the biology of melanoma cells. Non-immunological mechanisms.
Gattoni-Celli S; Calorini L; Simile MM; Ferrone S
Melanoma Res; 1993 Aug; 3(4):285-9. PubMed ID: 8219762
[TBL] [Abstract][Full Text] [Related]
7. [Antimetastatic effect of a liposome-entrapped synthetic analog of muramyl dipeptide].
Umanskiĭ VIu; Stefanov AV; Los' GV; Andronova TM; Balitskiĭ KP
Dokl Akad Nauk SSSR; 1986; 286(2):474-6. PubMed ID: 3004870
[No Abstract] [Full Text] [Related]
8. [Effect of novel derivatives of muramyl dipeptide on the immune system].
Kaliuzhin OV; Fuks BB; Bovin NV; Zemliakov AE; Chirva VIa
Biull Eksp Biol Med; 1994 May; 117(5):510-3. PubMed ID: 9296705
[No Abstract] [Full Text] [Related]
9. Immunostimulatory neem leaf preparation acts as an adjuvant to enhance the efficacy of poorly immunogenic B16 melanoma surface antigen vaccine.
Baral R; Mandal I; Chattopadhyay U
Int Immunopharmacol; 2005 Jul; 5(7-8):1343-52. PubMed ID: 15914339
[TBL] [Abstract][Full Text] [Related]
10. [Mechanism of action and clinical effectiveness of immunomodulator glucosaminylmuramyl dipeptide (licopide)].
Ivanov VT; Andronova TM; Nesmeianov VA; Pinegin BV; Ledger P; Bomford R; Khaitov RM
Klin Med (Mosk); 1997; 75(3):11-5. PubMed ID: 9229604
[No Abstract] [Full Text] [Related]
11. Behavioural effects of muramyl dipeptide and adamantylamide dipeptide in mice.
Sulcová A; Krsiak M; Masek K; Gulda O
Act Nerv Super (Praha); 1989 Jun; 31(2):127-9. PubMed ID: 2800947
[No Abstract] [Full Text] [Related]
12. [Effect of suppressive and activating glycoconjugates on lymphocytes].
Fuks BB
Vestn Akad Med Nauk SSSR; 1990; (2):39-42. PubMed ID: 2192515
[No Abstract] [Full Text] [Related]
13. Ferritin contributes to melanoma progression by modulating cell growth and sensitivity to oxidative stress.
Baldi A; Lombardi D; Russo P; Palescandolo E; De Luca A; Santini D; Baldi F; Rossiello L; Dell'Anna ML; Mastrofrancesco A; Maresca V; Flori E; Natali PG; Picardo M; Paggi MG
Clin Cancer Res; 2005 May; 11(9):3175-83. PubMed ID: 15867210
[TBL] [Abstract][Full Text] [Related]
14. A novel immunostimulator, N-[alpha-O-benzyl-N-(acetylmuramyl)-L-alanyl-D-isoglutaminyl]-N6-trans-(m-nitrocinnamoyl)-L-lysine, and its adjuvancy on the hepatitis B surface antigen.
Yang HZ; Xu S; Liao XY; Zhang SD; Liang ZL; Liu BH; Bai JY; Jiang C; Ding J; Cheng GF; Liu G
J Med Chem; 2005 Aug; 48(16):5112-22. PubMed ID: 16078831
[TBL] [Abstract][Full Text] [Related]
15. Activation of tumoricidal properties in murine macrophages by intravenous injection of muramyl dipeptide encapsulated within liposomes as a treatment for spontaneous metastasis.
Fidler IJ; Poste G
Prog Clin Biol Res; 1981; 75B():257-67. PubMed ID: 7323097
[No Abstract] [Full Text] [Related]
16. Mechanisms of tumor growth inhibition.
Steplewski Z; Herlyn D; Lubeck M; Kimoto Y; Herlyn M; Koprowski H
Hybridoma; 1986 Jul; 5 Suppl 1():S59-64. PubMed ID: 3744386
[No Abstract] [Full Text] [Related]
17. Overexpression of melanoma inhibitory activity (MIA) enhances extravasation and metastasis of A-mel 3 melanoma cells in vivo.
Guba M; Bosserhoff AK; Steinbauer M; Abels C; Anthuber M; Buettner R; Jauch KW
Br J Cancer; 2000 Nov; 83(9):1216-22. PubMed ID: 11027436
[TBL] [Abstract][Full Text] [Related]
18. Macrophage-mediated destruction of malignant tumor cells and new strategies for the therapy of metastatic disease.
Fidler IJ; Poste G
Springer Semin Immunopathol; 1982; 5(2):161-74. PubMed ID: 6755782
[No Abstract] [Full Text] [Related]
19. [Metastatic phenotype of a substrain of human melanoma Mel-7 transplanted into various immunodeficient mice].
Bryzgalov IP; Sorokina IuD; Deev VV; Kaminskaia TE; Revazova ES
Biull Eksp Biol Med; 1996 Dec; 122(12):655-7. PubMed ID: 9280466
[No Abstract] [Full Text] [Related]
20. Recent advances concerning the use of muramyl dipeptide derivatives as vaccine potentiators.
Audibert F; Chedid L
Prog Clin Biol Res; 1980; 47():325-38. PubMed ID: 7010376
[No Abstract] [Full Text] [Related]
[Next] [New Search]
